Skip to end of metadata
Go to start of metadata

Element Name

 

bcr_patient_barcode

 

additional_pharmaceutical_therapy

null

additional_radiation_therapy

null

additional_surgery_locoregional_procedure

null

additional_surgery_metastatic_procedure

null

adjuvant_postop_targeted_therapy_admin_indicator

null

age_at_initial_pathologic_diagnosis

 

ajcc_cancer_staging_handbook_edition

 

anatomic_site_location_descriptor

 

axillary_lymph_node_stage_method_type

 

axillary_lymph_node_stage_other_method_descriptive_text

 

breast_cancer_optical_measurement_histologic_type

 

breast_cancer_surgery_margin_status

 

breast_carcinoma_estrogen_receptor_status

 

breast_carcinoma_first_surgical_procedure_name

 

breast_carcinoma_immunohistochemistry_pos_cell_score

 

breast_carcinoma_progesterone_receptor_status

 

breast_carcinoma_surgical_procedure_name

 

breast_neoplasm_other_surgical_procedure_descriptive_text

 

breast_tumor_clinical_m_stage

 

breast_tumor_pathologic_grouping_stage

 

breast_tumor_pathologic_n_stage

 

breast_tumor_pathologic_t_stage

 

cytokeratin_immunohistochemistry_staining_method_micrometastasis_indicator

 

days_to_additional_surgery_locoregional_procedure

null

days_to_additional_surgery_metastatic_procedure

null

days_to_birth

 

days_to_death

 

days_to_form_completion

 

days_to_index

null

days_to_initial_pathologic_diagnosis

 

days_to_last_followup

 

days_to_last_known_alive

 

days_to_new_tumor_event_after_initial_treatment

null

disease_surgical_margin_status

 

drugs

null

er_detection_method_text

 

er_level_cell_percentage_category

 

ethnicity

 

first_nonlymph_node_metastasis_anatomic_site

 

first_pathologic_diagnosis_biospecimen_acquisition_method_type

 

first_pathologic_diagnosis_biospecimen_acquisition_other_method_text

null

first_recurrent_non_nodal_metastatic_anatomic_site_descriptive_text

null

fluorescence_in_situ_hybridization_diagnostic_procedure_chromosome_17_signal_result_range

 

gender

 

her2_and_centromere_17_positive_finding_other_measurement_scale_text

 

her2_erbb_method_calculation_method_text

 

her2_erbb_pos_finding_cell_percent_category

 

her2_erbb_pos_finding_fluorescence_in_situ_hybridization_calculation_method_text

 

her2_immunohistochemistry_level_result

 

her2_neu_and_centromere_17_copy_number_analysis_input_total_number_count

 

her2_neu_and_centromere_17_copy_number_metastatic_breast_carcinoma_analysis_input_total_number_count

null

her2_neu_breast_carcinoma_copy_analysis_input_total_number

 

her2_neu_chromosone_17_signal_ratio_value

 

her2_neu_metastatic_breast_carcinoma_copy_analysis_input_total_number

 

icd_o_3_histology

 

icd_o_3_site

 

immunohistochemistry_positive_cell_score

 

informed_consent_verified

 

lab_proc_her2_neu_immunohistochemistry_receptor_status

 

lab_procedure_her2_neu_in_situ_hybrid_outcome_type

 

lymph_node_examined_count

 

metastatic_breast_carcinoma_erbb2_immunohistochemistry_level_result

 

metastatic_breast_carcinoma_estrogen_receptor_detection_method_text

 

metastatic_breast_carcinoma_estrogen_receptor_level_cell_percent_category

 

metastatic_breast_carcinoma_estrogen_receptor_status

 

metastatic_breast_carcinoma_fluorescence_in_situ_hybridization_diagnostic_proc_centromere_17_signal_result_range

 

metastatic_breast_carcinoma_her2_erbb_method_calculation_method_text

 

metastatic_breast_carcinoma_her2_erbb_pos_finding_cell_percent_category

 

metastatic_breast_carcinoma_her2_erbb_pos_finding_fluorescence_in_situ_hybridization_calculation_method_text

 

metastatic_breast_carcinoma_her2_neu_chromosone_17_signal_ratio_value

 

metastatic_breast_carcinoma_immunohistochemistry_er_pos_cell_score

 

metastatic_breast_carcinoma_immunohistochemistry_pr_pos_cell_score

 

metastatic_breast_carcinoma_lab_proc_her2_neu_immunohistochemistry_receptor_status

 

metastatic_breast_carcinoma_lab_proc_her2_neu_in_situ_hybridization_outcome_type

 

metastatic_breast_carcinoma_pos_finding_her2_erbb2_other_measure_scale_text

null

metastatic_breast_carcinoma_pos_finding_other_scale_measurement_text

null

metastatic_breast_carcinoma_pos_finding_progesterone_receptor_other_measure_scale_text

null

metastatic_breast_carcinoma_progesterone_receptor_detection_method_text

null

metastatic_breast_carcinoma_progesterone_receptor_level_cell_percent_category

 

metastatic_breast_carcinoma_progesterone_receptor_status

 

patient_id

 

person_menopause_status

 

person_neoplasm_cancer_status

 

pgr_detection_method_text

 

pos_finding_her2_erbb2_other_measurement_scale_text

 

pos_finding_lymph_node_hematoxylin_and_eosin_staining_microscopy_count

 

pos_finding_lymph_node_keratin_immunohistochemistry_staining_method_count

 

pos_finding_metastatic_breast_carcinoma_estrogen_receptor_other_measuremenet_scale_text

null

pos_finding_progesterone_receptor_other_measurement_scale_text

 

positive_finding_estrogen_receptor_other_measurement_scale_text

 

pretreatment_history

 

primary_other_site_of_disease_name

 

prior_diagnosis

 

progesterone_receptor_level_cell_percent_category

 

race

 

radiation_therapy

null

radiations

null

surgical_procedure_purpose_other_text

 

tissue_prospective_collection_indicator

 

tissue_retrospective_collection_indicator

 

tissue_source_site

 

tumor_other_histologic_subtype_descriptive_text

 

tumor_tissue_site

 

vital_status

 

year_of_initial_pathologic_diagnosis

 

  • No labels